Oasis Fertility, a speciality healthcare startup, has announced that it has raised $50 million from Kedaara Capital. The private equity firm will support the startup in making strategic headways in the current market. “Oasis has created a scalable, replicable model and espouses a unique culture with clinical excellence and ethics at its core," said Nishant Sharma, CIO & Managing Partner of Kedaara Capital.

As per the company’s statement, a significant minority stake was bought by Kedaara Capital worth $50 million, with a commitment to deploy further capital for strategic acquisitions and support Oasis in becoming the leading fertility chain in India and adjacent markets. The transaction will also provide an exit to InvAscent, who invested in the company in 2016.

The funding will be utilised to expand the company's brand presence across India and hire support staff to manage the increase in demand for speciality healthcare-based services.

Kiran Gadela, Co-founder and Managing Director, Oasis Fertility said, “We are delighted about leveraging Kedaara’s understanding of the sector and the Indian market. We look forward to this partnership as we embark on a journey to pursue attractive synergistic acquisitions and create a leading fertility platform in India and South Asia to further our core purpose of helping couples achieve parenthood.”

Founded in 2009 by Dr Durga G. Rao and Kiran Gadela, the Hyderabad based startup has scaled to a network of 26 clinics across 16 cities while doubling its revenues in the last three years. Oasis recently launched first-of-its-kind andrology (male infertility) practice called AndroLife.

O3 Capital acted as the exclusive financial advisor for the transaction. Samvad Partners, Quillon Partners and Veritas Legal were the legal counsels to Oasis, InvAscent and Kedaara Capital.